Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07863986
Recruiting
Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Not applicable · Lithuania · 1 site
Registry update: 14 Oct 2026
NCT07220187
Recruiting
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
Phase 3 · United States · 62 sites
Registry update: 13 Oct 2026
NCT07282613
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Phase 3 · Argentina, Brazil, Colombia, Israel, India, Mexico, Malaysia, Thailand, Taiwan, United States · 58 sites
Registry update: 19 Oct 2026
NCT07795749
Recruiting
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
Phase 2 · United States · 1 site
Registry update: 31 Aug 2026
NCT07851454
Recruiting
Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease
Not applicable · Spain · 1 site
Registry update: 1 Oct 2026
NCT07680153
Recruiting
Neuromodulation of Mood Switch Circuitry in Bipolar Disorder
Phase 4 · United States · 1 site
Registry update: 23 Sept 2026
NCT07630168
Recruiting
Effects of Infusion Timing on Treatment Response in Solid Tumors
Phase 2 · United States · 1 site
Registry update: 15 Sept 2026
NCT07516093
Recruiting
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Phase 3 · United States · 6 sites
Registry update: 31 Aug 2026
NCT07310862
Recruiting
Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis
Not applicable · Spain · 1 site
Registry update: 22 Oct 2026
NCT07675499
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
Phase 2/3 · United States · 4 sites
Registry update: 30 Jun 2026
NCT06251544
Recruiting
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Phase 1 · United States · 1 site
Registry update: 24 Sept 2026
NCT07227896
Recruiting
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
Not applicable · United Kingdom, Israel, Romania, United States · 10 sites
Registry update: 1 Sept 2026
NCT07374640
Recruiting
Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness
Early phase 1 · United States · 1 site
Registry update: 22 Oct 2026
NCT07582458
Recruiting
Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)
Phase 2/3 · Netherlands · 2 sites
Registry update: 14 Sept 2026
NCT07762573
Recruiting
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
Not applicable · China · 1 site
Registry update: 13 Aug 2026
NCT07709650
Recruiting
Hypofractionated Chemoradiotherapy for Cervical Cancer
Phase 3 · Thailand · 1 site
Registry update: 24 Aug 2026
NCT07723248
Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Phase 3 · Puerto Rico, United States · 15 sites
Registry update: 3 Nov 2026
NCT07702643
Recruiting
Behavioral Intervention and Guided Stepping Training Early Post-Stroke
Not applicable · Canada · 6 sites
Registry update: 23 Oct 2026
2024-514744-91-00
Recruiting
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX304
Phase 1 · Germany · 1 site
Registry update: 30 Jul 2026
NCT07545954
Recruiting
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
Phase 1 · United States · 1 site
Registry update: 4 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.